NCT03402685View on ClinicalTrials.gov

Continuous Non-invasive Blood Pressure Measurement in C-section

NACompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

May 17, 2018

Primary Completion Date

December 31, 2019

Study Completion Date

June 1, 2020

Conditions
Cesarean Delivery Affecting NewbornCesarean Delivery Affecting FetusCesarean Section Complications
Interventions
DEVICE

ClearSight

Patients in the intervention group receive management of volume and vasopressor settings according to the non-invasive ClearSight system.

Trial Locations (1)

10117

Charité - Universitätsmedizin Berlin, Berlin

All Listed Sponsors
lead

Charite University, Berlin, Germany

OTHER

NCT03402685 - Continuous Non-invasive Blood Pressure Measurement in C-section | Biotech Hunter | Biotech Hunter